10 Tips in 2 Minutes - The Business of Biotech - August 8, 2010 - Segment Five
Ten Tips in 2 Minutes - The Business of Biotech - Betsy and Renee review their tips on how customized and personal healthcare consultants and concierges could be very lucrative fields to enter as an entrepreneur.
2Minutes&More with Betsy Berkhemer and Renee Fraser airs every Sunday at 1pm on KFWB NEWS TALK 980. Tune in for a full hour of tips for business success.
The Business of Biotech - Interview with Julie Meyer Wright, President and CEO, San Diego Regional Economic Development Corporation - August 8, 2010 - Segment Four
The Business of Biotech - Julie Meyer Wright, President & CEO, San Diego Regional Economic Development Corporation. Renee and Betsy discuss with Julie the opportunities available in life sciences and biotech fields especially in the San Diego Region. They coined the phrase “San Diego, Technology’s Perfect Climate”. She also talks about her experience as she went through the genome sequencing test and how you can use the information from the results to make lifestyle changes if necessary if you are predisposed to any type of disease.
2Minutes&More with Betsy Berkhemer and Renee Fraser airs every Sunday at 1pm on KFWB NEWS TALK 980. Tune in for a full hour of tips for business success.
The Business of Biotech - Interview with Jay Flatley, CEO of Illumina, Part Two - August 8, 2010 - Segment Three
The Business of Biotech - Interview with Jay Flatley, Chief Executive Officer, Illumina Inc.
Prior to his appointment in 1999 as president and chief executive officer of Illumina, Jay was the president and chief executive officer of Molecular Dynamics, later acquired by Amersham Pharmacia Biotech and now a part of GE Healthcare. As a co-founder and member of the board of directors for Molecular Dynamics he led the Company to its initial public offering in 1993. While there, he also helped Molecular Dynamics develop and launch over 15 major instrumentation systems, including the first capillary-based DNA sequencer.
Prior to joining Molecular Dynamics, Jay was vice president of engineering and strategic planning for Plexus Computers, a manufacturer of high-performance Unix super-microcomputers. Before his career at Plexus, Jay was executive vice president for Manning Technologies and held various manufacturing positions while working for the Autolab division of Spectra Physics. Currently, he is a member of the board of directors for both Illumina and GenVault Corporation and is a member of the Keck Graduate Institute board of trustees.
Jay received a B.A. in economics from Claremont McKenna College and a B.S. and M.S. (summa cum laude) in industrial engineering from Stanford University.
2Minutes&More with Betsy Berkhemer and Renee Fraser airs every Sunday at 1pm on KFWB NEWS TALK 980. Tune in for a full hour of tips for business success.
The Business of Biotech - Interview with Jay Flatley, CEO of Illumina, Part One - August 8, 2010 - Segment Two
The Business of Biotech - Interview with Jay Flatley, Chief Executive Officer of Illumina, specializing in genome sequencing. Illumina’s Individual Genome Sequencing service can provide you with the most comprehensive information on your genome from the world’s experts in genetic analysis. Learn about your ancestry, potential response to drugs, and predisposition to health conditions. Uncover your story.
Illumina was founded in 1998 with the vision of becoming the world’s leading provider of integrated tools and services that advance the understanding of genetics and health. Today, their platforms and assays are helping make studies possible that were not even imaginable just a few years ago. Whether enabling researchers to discovering the genetic underpinnings of disease risk or individuals to better understand their genome, their technologies provide the most accurate, comprehensive translation of what’s present in our DNA.
2Minutes&More with Betsy Berkhemer and Renee Fraser airs every Sunday at 1pm on KFWB NEWS TALK 980. Tune in for a full hour of tips for business success.

Subscribe to News
